{
    "nctId": "NCT00050349",
    "officialTitle": "Just test of only first line of trial to compare to modifiers",
    "inclusionCriteria": "Patients with biopsy-proven metastatic carcinoid tumors or other neuroendocrine tumors (Islet cell, Gastrinomas, and VIPomas) with at least one measurable lesion (other than bone) that has either not been previously irradiated or if previously irradiated has demonstrated progression since the radiation therapy."
}